Illumina TruSight Oncology 500 ctDNA Liquid Biopsy Panel: Application within Almac Diagnostic Services Laboratory

Time investment: 30mins

In this webinar presentation, recorded with kind permission from Illumina at their recent Comprehensive Genomic Profiling (CGP) event, hear from Killian McSorley, Assay Validation and Development Manager at Almac Diagnostic Services.

Killian will cover the outcome of an Almac laboratory study as an initial assessment of the performance of the TSO-500 ctDNA assay, using a small cohort of samples and controls. The study objectives were as follows:

• Assess technical performance of sensitivity and repeatability
• Assess concordance of genomic aberrations reported in liquid samples with those detected in solid tumor using the FFPE TSO-500 assay
• Determine the effect of variance in library prep template input with respect to the two factors above
• Finalize a protocol to be used for routine delivery of the assay

Agenda

• Overview of Almac Diagnostic Services and our Laboratory Solutions
• Opportunity & Benefit of Liquid Biopsy
• Almac’s experience of the TSO-500 ctDNA Assay in our Laboratories
• Utilization of TSO-500 ctDNA within Oncology

Note: The Illumina TruSight Oncology 500 ctDNA Panel is for Research Use Only (RUO). Not for use in diagnostic procedures.